Approach to the Hypophosphatemic Patient

被引:111
作者
Imel, Erik A. [2 ]
Econs, Michael J. [1 ,3 ]
机构
[1] Indiana Univ Sch Med, Div Endocrinol & Metab, Dept Med, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
X-LINKED HYPOPHOSPHATEMIA; FIBROBLAST GROWTH FACTOR-23; TUMOR-INDUCED OSTEOMALACIA; THRESHOLD PHOSPHATE CONCENTRATION; D-RESISTANT RICKETS; ONCOGENIC OSTEOMALACIA; PHOSPHORUS THERAPY; MECHANICAL VENTILATION; HOSPITALIZED-PATIENTS; COMPUTED-TOMOGRAPHY;
D O I
10.1210/jc.2011-1319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypophosphatemia is commonly missed due to nonspecific signs and symptoms, but it causes considerable morbidity and in some cases contributes to mortality. Three primary mechanisms of hypophosphatemia exist: increased renal excretion, decreased intestinal absorption, and shifts from the extracellular to intracellular compartments. Renal hypophosphatemia can be further divided into fibroblast growth factor 23-mediated or non-fibroblast growth factor 23-mediated causes. Proper diagnosis requires a thorough medication history, family history, physical examination, and assessment of renal tubular phosphate handling to identify the cause. During the past decade, our understanding of phosphate metabolism has grown greatly through the study of rare disorders of phosphate homeostasis. Treatment of hypophosphatemia depends on the underlying disorder and requires close biochemical monitoring. This article illustrates an approach to the hypophosphatemic patient and discusses normal phosphate metabolism. (J Clin Endocrinol Metab 97: 696-706, 2012)
引用
收藏
页码:696 / 706
页数:11
相关论文
共 83 条
[1]   Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors [J].
Andreopoulou, Panagiota ;
Dumitrescu, Claudia E. ;
Kelly, Marilyn H. ;
Brillante, Beth A. ;
Peck, Carolee M. Cutler ;
Wodajo, Felasfa M. ;
Chang, Richard ;
Collins, Michael T. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (06) :1295-1302
[2]   The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency [J].
Bai, XY ;
Miao, DS ;
Goltzman, D ;
Karaplis, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9843-9849
[3]   LINEAR GROWTH IN PATIENTS WITH HYPOPHOSPHATEMIC VITAMIN-D RESISTANT RICKETS - INFLUENCE OF TREATMENT REGIMEN AND PARENTAL HEIGHT [J].
BALSAN, S ;
TIEDER, M .
JOURNAL OF PEDIATRICS, 1990, 116 (03) :365-371
[4]   Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism [J].
Bellini, E. ;
Pia, A. ;
Brizzi, M. P. ;
Tampellini, M. ;
Torta, M. ;
Terzolo, M. ;
Dogliotti, L. ;
Berruti, A. .
ANNALS OF ONCOLOGY, 2011, 22 (04) :988-U1501
[5]   SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis [J].
Bergwitz, C ;
Roslin, NM ;
Tieder, M ;
Loredo-Osti, JC ;
Bastepe, M ;
Abu-Zahra, H ;
Frappier, D ;
Burkett, K ;
Carpenter, O ;
Anderson, D ;
Garabédian, M ;
Sermet, I ;
Fujiwara, TM ;
Morgan, K ;
Tenenhouse, HS ;
Jüppner, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 78 (02) :179-192
[6]   Post-transplant hypophosphatemia:: Tertiary 'hyper-phosphatoninism'? [J].
Bhan, I. ;
Shah, A. ;
Holmes, J. ;
Isakova, T. ;
Gutierrez, O. ;
Burnett, S-A ;
Jueppner, H. ;
Wolf, M. .
KIDNEY INTERNATIONAL, 2006, 70 (08) :1486-1494
[7]   Hypophosphatemia: Clinical consequences and management [J].
Brunelli, Steven M. ;
Goldfarb, Stanley .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (07) :1999-2003
[8]  
CAMP MA, 1990, MINER ELECTROL METAB, V16, P365
[9]   A Clinician's Guide to X-Linked Hypophosphatemia [J].
Carpenter, Thomas O. ;
Imel, Erik A. ;
Holm, Ingrid A. ;
de Beur, Suzanne M. Jan ;
Insogna, Karl L. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (07) :1381-1388
[10]   NOCTURNAL HYPERPARATHYROIDISM - A FREQUENT FEATURE OF X-LINKED HYPOPHOSPHATEMIA [J].
CARPENTER, TO ;
MITNICK, MA ;
ELLISON, A ;
SMITH, C ;
INSOGNA, KL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1378-1383